3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
The Motley Fool | May 03, 2017
Shares of Teva Pharmaceutical Industries (NYSE:TEVA), a developer of brand-name drugs and the largest manufacturer of generic drugs in the world, continued its fairly steady.